Skip to main content
SpringerLink
Log in

The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration

Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Whether the pathophysiology and treatment of neurolepticinduced oral dyskinesias in rats parallel that for tardive dyskinesia in humans remains a question. To address the issue further, Sprague Dawley rats were treated for 6 months with multiple oral doses of haloperidol (1.5 and 3.0 mg/ kg/day) or clozapine (10, 20, and 30 mg/kg/day) and compared with water treated animals. The rate of oral dyskinesias was monitored at study start and monthly by trained raters who were blind to treatment group. All haloperidoltreated rats developed oral dyskinesias at a significantly higher rate than rats treated with water (p=0.0007) or those treated with clozapine (p=0.0017). Each dose of haloperidol produced significantly higher rates of oral dyskinesias than did any dose of clozapine and did so in an apparent dose-sensitive manner. Clozapine lacked a dose-sensitive relationship with the oral dyskinesias, and failed to show a significant difference in rate from control rats at any dose. Plasma levels of haloperidol with these doses were in the human therapeutic range; with clozapine only the highest dose produced plasma levels in the human therapeutic range. These data show little association between rat oral dyskinesias and clozapine treatment, whereas a strong association is present with haloperidol. The data are, thereby, consistent with the clinical association of tardive dyskinesia with typical neuroleptics like haloperidol but not with the atypical neuroleptic clozapine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bianchetti G, Morselli PL (1978) Rapid and sensitive method for determination of haloperidol in human samples using nitrogen-phosphorous selection detection. J Chromatogr 153: 203–210

    PubMed  Google Scholar 

  • Clow JM (1980) Changes in cerebral dopamine treatment, long term effects of neuroleptics. Adv Biochem Psychopharmacol 24: 134–139

    Google Scholar 

  • Centorrino F, Baldessarini RJ, Kando J, Frankenburg FR, Volpicelli SA, Puopolo PR, Flood JG (1994) Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry 151: 123–125

    PubMed  Google Scholar 

  • Dave M (1994) Clozapine-related tardive dyskinesia: case report. Biol Psychiatry 35: 886–887

    PubMed  Google Scholar 

  • Gao XM, Kakigi T, Friedman MB, Tamminga CA (1994) Tigabine inhibits haloperidol-induced oral dyskinesias in rats. J Neural Transm [Gen Sect] 95: 63–69

    Google Scholar 

  • Gerlach J, Peacock L (1994) Extrapyramidal symptoms during long-term treatment with antipsychotics: special focus on clozapine, D1 and D2 dopamine antagonists. Collegium International Neuro-Psychopharmacologicum Congress, Washington, DC, June 28, 1994

  • Gunne LM, Growdon J, Glaeser B (1982) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77: 134–139

    PubMed  Google Scholar 

  • Gunne LM, Haggstrom JE, Sjoqust B (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309: 347–349

    PubMed  Google Scholar 

  • Gunne LM, Andersson U, Bondesson U, Johansson P (1986) Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol Biochem Behav 25: 897–901

    PubMed  Google Scholar 

  • Hashimoto T, Gao XM, Shirakawa O, Kakigi T, Tobin AJ, Tamminga CA (1994) Effect of chronic neuroleptic administration on rat oral dyskinesia and the mRNA expression of GAD enkephalin and substance p. Neurosci Abstr 20: 667.10

    Google Scholar 

  • Hyttel J (1991) Sertindole: a new concept in neuroleptic research. Biol Psychiatry 29: 553–555

    Google Scholar 

  • Iversen SD, Howells RB, Hughes RF (1980) Behavioral consequences of long-term treatment with neuroleptic drugs. Adv Biochem Psychopharmacol 24: 305–313

    PubMed  Google Scholar 

  • Kakigi T, Gao X-M, Tamminga CA (1995) Drug-induced oral dyskinesias in rats after traditional and new neuroleptics. J Neural Transm [Gen Sect] 101: 41–49

    Google Scholar 

  • Kane JM, Woerner M, Liebermann J (1985) Tardive dyskinesia: prevalence incidence, and risk factors. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Springer, Berlin Heidelberg New York Tokyo, pp 72–78

    Google Scholar 

  • Kane JM, Woerner MG, Pollack S (1993) Does clozapine cause tardive dyskinesia? J Clin Psychiatry 54: 327–330

    PubMed  Google Scholar 

  • Kaneda H, Shirakawa O, Dale J, Goodman L, Bachus SE, Tamminga CA (1992) Coadministration of progabide inhibits haloperidol-induced oral dysknesias in rats. Eur J Pharmacol 212: 43–49

    PubMed  Google Scholar 

  • Kohler C, Hall H, Magnusson O (1990) Biochemical pharmacology of the atypical neuroleptic remoxipride. Acta Psychiatr Scand [Suppl] 358: 27–36

    Google Scholar 

  • Lidow MS, Goldman-Rakic PS (1994) A common action of clozapine, haloperidol and remoxipride no D1 and D2-dopaminergic receptors in the primate cerebral cortex. Proc Natl Acad Sci USA 91: 4353–4356

    PubMed  Google Scholar 

  • McKinney WT Jr, Bunney WE Jr (1969) Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry 21: 240–248

    PubMed  Google Scholar 

  • Mithani S, Atmadja S, Baimbridge KG, Fibinger HC (1987) Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Psychopharmacology 93: 94–100

    PubMed  Google Scholar 

  • Rupniak NMJ, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD (1984) Differential effects of continuous adminstration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Psychopharmacology 4: 503–511

    Google Scholar 

  • Shirakawa O, Tamminga CA (1994) Basal ganglia GABAA and dopamine D binding site correlates of haloperidol-induced oral dyskinesia as in rats. Exp Neurol 127: 62–69

    PubMed  Google Scholar 

  • Simpson GM, Cooper TB (1978) Clozapine plasma levels and convulsions. Am J Psychiatry 135: 99–100

    PubMed  Google Scholar 

  • Skarsfeldt T, Perregaard J (1990) Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat. Eur J Pharmacol 182: 613–614

    PubMed  Google Scholar 

  • Tamminga CA, Dale JM, Goodman L, Kaneda H, Kaneda N (1990) Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology 102: 474–478

    PubMed  Google Scholar 

  • Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao X-M (1994) Clozapine in tardive dyskinesia: observations from human and animal model studies. J Psych Res 55: 102–106

    Google Scholar 

  • Tarazi FI, Florijn WI, Creese I (1994) Regulation of dopamine receptor binding following chronic neuroleptic treatment. Center for Molecular and Behavioral Neuroscience, Rutgers University, Newark NJ. Neurosci Abstr 726.2

    Google Scholar 

  • Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101: 431–447

    PubMed  Google Scholar 

  • Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1982) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220: 530–532

    Google Scholar 

Download references

Author information

Author notes

  1. X. M. Gao

    Present address: Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland, Baltimore, MD

Authors and Affiliations

  1. Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland, Baltimore, MD

    T. Hashimoto & C. A. Tamminga

  2. Nathan S. Kline Institute for Psychiatric Research, Orangeburg, N.Y., USA

    T. B. Cooper

Authors
  1. X. M. Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. B. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. A. Tamminga
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, X.M., Hashimoto, T., Cooper, T.B. et al. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration. J. Neural Transmission 104, 97–104 (1997). https://doi.org/10.1007/BF01271298

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01271298

Keywords

search

Navigation